Company Analysis

Co-Diagnostics, Inc. (CODX)

Nasdaq: CODX · Surgical & Medical Instruments & Apparatus · Salt Lake City, UT · filing with the SEC since 2016
Grade3.5
◀ Past 3.4● Present 3.4▶ Future 3.5
1 est.

Who runs Co-Diagnostics, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Egan Dwight H
Chief Executive Officer. First filing Aug 2017, latest May 27, 2026, 2 filings in all.
Officers reporting now
4
of 9 people with a filing in the last fifteen months
Directors reporting now
5
13 people on the record since 2017
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Bohrer DanielEVP of Finance & AccountingSep 2026Sep 14, 2026none
Egan Dwight HChief Executive OfficerAug 2017May 27, 2026none
Abbott Richard DavidPresidentMar 2024May 27, 2026none
Brown Brian LeeChief Financial OfficerFeb 2021May 27, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Durenard EugenedirectorMay 2020May 27, 2026none
Murphy Edward L.directorNov 2019May 27, 2026none
Nelson James BdirectorNov 2019May 27, 2026none
Serbin Richard SdirectorAug 2017May 27, 2026none
Murphy TeddirectorJan 2022Aug 15, 2025none
Earlier names on the record7, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton CODX · research, not advice